Supernus Pharmaceuticals Inc (SUPN) — Cash Flow-to-Debt Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of $-4.81 Million could theoretically repay 0% of its total liabilities ($396.88 Million) in one year. See financial flexibility index of Supernus Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Supernus Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Supernus Pharmaceuticals Inc across 18 annual periods. For the full cash flow conversion analysis, see Supernus Pharmaceuticals Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Supernus Pharmaceuticals Inc (2008–2025)
Year-by-year debt coverage analysis for Supernus Pharmaceuticals Inc. Check earnings quality score of Supernus Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $47.33 Million | $390.93 Million | ▼ -76.6% |
| 2024 | 0.52x | $171.95 Million | $332.34 Million | ▲ +65.9% |
| 2023 | 0.31x | $111.08 Million | $356.16 Million | ▲ +117.9% |
| 2022 | 0.14x | $116.83 Million | $816.30 Million | ▼ -1.7% |
| 2021 | 0.15x | $127.13 Million | $873.30 Million | ▼ -20.1% |
| 2020 | 0.18x | $138.40 Million | $759.24 Million | ▼ -28.1% |
| 2019 | 0.25x | $143.13 Million | $564.85 Million | ▲ +3.1% |
| 2018 | 0.25x | $128.99 Million | $524.79 Million | ▼ -66.3% |
| 2017 | 0.73x | $114.64 Million | $156.98 Million | ▲ +28.8% |
| 2016 | 0.57x | $66.81 Million | $117.81 Million | ▲ +23.3% |
| 2015 | 0.46x | $32.12 Million | $69.86 Million | ▲ +293.4% |
| 2014 | 0.12x | $7.73 Million | $66.15 Million | ▲ +115.6% |
| 2013 | -0.75x | $-57.95 Million | $77.53 Million | ▲ +42.3% |
| 2012 | -1.30x | $-47.20 Million | $36.42 Million | ▼ -58.6% |
| 2011 | -0.82x | $-36.19 Million | $44.29 Million | ▼ -129.3% |
| 2010 | -0.36x | $-32.54 Million | $91.33 Million | ▼ -1264.2% |
| 2009 | 0.03x | $2.63 Million | $86.06 Million | ▲ +108.7% |
| 2008 | -0.35x | $-29.65 Million | $83.88 Million | — |